FOX D3 Enhancer Vectors for Neural Crest Cell Isolation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack effective tools for identifying and isolating early stage embryonic neural crest cells, which are crucial for understanding cell specification and differentiation during development, due to the complexity of neural crest gene regulatory networks.

Innovation Solution

Identification and isolation of specific DNA enhancer sequences that can be used in constructs to target early stage embryonic neural crest cells, combined with short-hairpin RNA for gene knockdown, allowing for the isolation and manipulation of these cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current methods are used to identify and isolate early stage embryonic neural crest cells, then the complexity of neural crest gene regulatory networks cannot be effectively managed, but the ability to identify and isolate these cells remains insufficient

Engineering Contradiction:
Improveidentification precisionVSAvoidmethod complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the complex neural crest gene regulatory network into specific modular enhancer elements (SOX10E1, SOX10E2, NC1, NC2, SC1) that can be individually isolated and manipulated. Each enhancer module controls specific aspects of neural crest cell specification and differentiation, allowing researchers to study and manipulate the system in discrete, manageable units rather than dealing with the entire complex network at once.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces reporter genes (such as GFP) as intermediary markers that are controlled by the isolated enhancer sequences. These reporter genes serve as measurable intermediaries that translate the complex regulatory activity of neural crest genes into easily detectable signals, enabling precise identification and isolation of neural crest cells without directly measuring the complex gene regulatory networks themselves.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If isolated enhancer sequences are used to identify neural crest cells, then isolation precision is improved, but the requirement for specific DNA constructs increases

Engineering Contradiction:
Improveisolation precisionVSAvoidconstruct complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent creates universal vector constructs that can accommodate multiple different enhancer sequences (SOX10E1, SOX10E2, NC1, NC2, SC1) and various reporter genes within a single standardized platform. This universal construct design allows the same basic vector to be used for studying different aspects of neural crest development by simply changing the inserted enhancer sequence, reducing the need to design entirely new constructs for each experimental condition.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Adaptability or versatility

If short-hairpin RNA is used for gene knockdown in neural crest cells, then gene expression control is improved, but the vector construct complexity increases

Engineering Contradiction:
Improvegene control capabilityVSAvoidvector complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent merges the short-hairpin RNA knockdown system with the enhancer-reporter vector constructs into a single integrated system. The short-hairpin RNA sequences are placed under the control of the same enhancer elements that drive reporter gene expression, allowing simultaneous visualization of neural crest cells and knockdown of specific genes within the same vector construct. This combination enables coordinated gene expression control and visualization without requiring separate vector systems.

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentUS8907073B2Nucleic acids encoding FOXD3 promoter and methods to isolate FOXD3 expressing cells
Publication Date: 2014.12.09 CALIFORNIA INST OF TECH
  • US8907073B2 patent drawing
  • US8907073B2 patent drawing
  • US8907073B2 patent drawing

AI summary

DNA enhancer sequences are provided for use in constructs to identify early stage embryonic cells. The enhancer sequences can be used in parallel with short-hairpin RNA in a vector construct for endogenously regulated gene knockdowns. The disclosed enhancer sequences can be used to isolate a selected population of early stage embryonic cells.